![](https://investorshub.advfn.com/uicon/179372.png?cb=1527790159)
Wednesday, July 04, 2018 6:47:07 AM
I, [Tim Warbington], [Chief Executive Officer] of [Creative Medical Technology Holdings, Inc.] (“the Company”),
certify that:
a. The Company is registered or required to file periodic reporting with the SEC or is exempt from SEC
registration as indicated below (mark the box below that applies with an “X”):
[ X ] Company is registered under Section 12(g) of the Exchange Act
[ ] Company is relying on Exchange Act Rule 12g3-2(b)
[ ] Company is a bank that reports to a Bank Regulator under Section 12(i) of the Exchange Act
[ ] Company is a bank that is non-SEC reporting but is current in its reporting to a Banking Regulator
[ ] Company is reporting under Section 15(d) of the Exchange Act.
[ ] Company is reporting under the Alternative Reporting Company Disclosure Guidelines
[ ] Other (describe)
b. The Company is current in its reporting obligations as of the most recent fiscal year end and any subsequent
quarters, and such information has been posted either on the SEC’s EDGAR system or the OTC Disclosure &
News Service, as applicable.
c. The Company Profile displayed on www.otcmarkets.com is current and complete as of March 31, 2018 and
includes the total shares outstanding, authorized, and in the public float as of that date.
d. Please provide the following information as of the latest practicable date:
i. Number of Beneficial Owners holding at least 100 shares: 90 as of March 31, 2018
(“Beneficial Owner” shall mean any person who, directly or indirectly has or shares voting power of such
security or investment power, which includes the power to dispose, or to direct the disposition of, such
security.)
ii. Number of shares in the Public Float: 525,079,355 as of June 27, 2018
(“Public Float” shall mean the total number of unrestricted shares not held directly or indirectly by an officer,
director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding, or
any Affiliates thereof, or any Immediate Family Members of officers, directors and control persons.)
e. The company is duly organized, validly existing and in good standing under the laws of Nevada in which the
Company is organized or does business.
f. Identify any law firm and attorney(s) that acted as the Company’s primary legal counsel in preparing its most
recent annual report. Include the firm and attorney(s) name if outside counsel, or name and title if internal counsel.
(If no attorney assisted in putting together the disclosure, the Company must identify the person or persons who
prepared the disclosure and their relationship to the company.) Please also identify any other attorney, if different
than the primary legal counsel, that assisted the company during the prior fiscal year on any matter including but
not limited to, preparation of disclosure, press releases, consulting services, corporate action or merger assistance,
etc.
Pearson, Butler & Carson, PLLC
Ronald N. Vance
g. The following is a complete list of third party providers, including names and addresses, engaged by the
Company, its officers, directors or controlling shareholders, during the period from the Company’s prior fiscal year
end to the date of this OTCQB Certification, to provide investor relations services, public relations services,
marketing, brand awareness, consulting, stock promotion, or any other related services to the Company.
h. The following is a complete list of Officers, Directors and Control Persons (control persons are beneficial owners
of more than five percent (5%) of any class of the issuer’s equity securities), including name, address, and number
of shares owned. Options and warrants that can be converted into common shares within the next 60 days should
be included in the shareholdings listed below. If any of the beneficial shareholders are corporate entities, provide
the name and address of the person(s) owning or controlling such corporate entities.
Timothy Warbington owns 74,977,884 shares as of June 29, 2018
Donald Dickerson owns 1,293,333
Thomas Ichim owns 2,586,667
Amit Patel owns 3,880,000
Creative Medical Holdings, Inc.
(Timothy Warbington) owns 68,511,217
Date: June 29, 2018
Name of Certifying CEO or CFO: Donld Dickerson
Title: CFO
Signature: /s/ Donald Dickerson
(Digital Signatures should appear as “/s/ [OFFICER NAME]”)
All posts are speculative and my opinion only. NOT investment advice.
Recent CELZ News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM